Dr Monica Robotin

Senior Lecturer
Public Health, School of Public Health

Telephone +61 2 9036 7137
Fax +61 2 9351 7420

Map

Selected publications & creative works

Download citations: PDF RTF Endnote

Edited Books

  • Oliver, I., Robotin, M. (2012). Perspectives on Complementary and Alternative Medicines. London: Imperial College Press.
  • Robotin, M., Olver, I., Girgis, A. (2010). When Cancer Crosses Disciplines: A Physician's Handbook. London: Imperial College Press.
  • Matthews, G., Robotin, M. (2008). B positive-all you wanted to know about hepatitis B: a guide for primary care providers. Australia: ASHM - Australasian Society for HIV Medicine.

Book Chapters

  • Robotin, M. (2012). From Traditional Medicines to Drug Discovery. In Olver, I and Robotin, M (Eds.), Perspectives on Complementary and Alternative Medicines, (pp. 157-185). London: Imperial College Press.
  • Robotin, M. (2011). Randomised Controlled Trials in the Primary Treatment of Hepatocellular Carcinoma. In Liang Qiao, Yumin Li, Xiang Yan & Jacob George (Eds.), Molecular Aspects of Hepatocellular Carcinoma, (pp. 174-195). Sharjah: Bentham Science Publishers Ltd.
  • Sundquist, K., Robotin, M. (2010). What matters to patients and to carers. In Monica Robotin, Ian Olver and Afaf Girgis (Eds.), When Cancer Crosses Disciplines: A Physician's Handbook, (pp. 317-341). London: Imperial College Press.
  • Robotin, M. (2008). Hepatitis b virus-related hepatocellular carcinoma. In Gail Matthews and Monica Robotin (Eds.), B positive-all you wanted to know about hepatitis B: a guide for primary care providers, (pp. 69-74). Australia: ASHM - Australasian Society for HIV Medicine.

Journals

  • Sitas, F., Gibberd, A., Kahn, C., Weber, M., Chiew, M., Supramaniam, R., Velentzis, L., Nickson, C., Smith, D., O'Connell, D., Yu, X., Canfell, K., Robotin, M., et al (2013). Cancer incidence and mortality in people aged less than 75 years: Changes in Australia over the period 1987-2007. Cancer Epidemiology, 37(6), 780-787. [More Information]
  • Robotin, M., Patton, Y., George, J. (2013). Getting it right: The impact of a continuing medical education program on hepatitis B knowledge of Australian primary care providers. International Journal of General Medicine, 6(115), 122. [More Information]
  • Robotin, M., Patton, Y., Kansil, M., Penman, A., George, J. (2012). Cost of treating chronic hepatitis B: Comparison of current treatment guidelines. World Journal of Gastroenterology, 18(42), 6106-6113. [More Information]
  • Robotin, M., Holliday, C., Bensoussan, A. (2012). Defining research priorities in complementary medicine in oncology. Complementary Therapies in Medicine, 20(5), 345-352. [More Information]
  • Robotin, M. (2011). Botanical products in the 21st century: from whence to whither. Cancer Forum, 35(1), 6-9.
  • Robotin, M. (2011). Hepatitis B prevention and control: Lessons from the East and the West. World Journal of Hepatology, 3(2), 31-37. [More Information]
  • Robotin, M., Jones, S., Biankin, A., Waters, L., Iverson, D., Gooden, H., Barraclough, B., Penman, A. (2010). Defining research priorities for pancreatic cancer in Australia: results of a consensus development process. Cancer Causes and Control: an international journal of studies of cancer in human populations, 21(5), 729-736. [More Information]
  • Robotin, M. (2010). Enquiring about cancer patients' use of complementary and alternative medicines: Is our job done? Asia-Pacific Journal of Clinical Oncology, 6(4), 245-247. [More Information]
  • Holliday, C., Robotin, M. (2010). The Delphi process: a solution for reviewing novel grant applications. International Journal of General Medicine, 3, 225-230. [More Information]
  • Robotin, M., Kansil, M., George, J., Howard, K., Tipper, S., Levy, M., Phung, N., Penman, A. (2010). Using a population-based approach to prevent hepatocellular cancer in New South Wales, Australia: effects on health services utilisation. BMC Health Services Research, 10, 215-224. [More Information]
  • Robotin, M., Kansil, M., Howard, K., George, J., Tipper, S., Dore, G., Levy, M., Penman, A. (2009). Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screening. Journal of Hepatology, 50(5), 990-998. [More Information]
  • Saunders, C., Gooden, H., Robotin, M., Mumford, J. (2009). As the bell tolls: a foundation study on pancreatic cancer consumer's research priorities. BMC Research Notes, 2(179), 1-9. [More Information]
  • Alam, N., Robotin, M., Baker, D. (2009). Epidemiology of primary liver cancer. Cancer Forum, 33(2), 88-92.
  • George, J., Robotin, M. (2009). Overview: Hepatocellular carcinoma - the future starts now. Cancer Forum, 33(2), 83-87.
  • Saunders, C., Robotin, M., Crossing, S. (2008). By invitation only - the case for breast cancer screening reminders for women over 69 years. Australia and New Zealand Health Policy, 5(23), 23-1-23-6. [More Information]
  • Supramaniam, R., O'Connell, D., Robotin, M., Tracey, E., Sitas, F. (2008). Future cancer trends to be influenced by past and future migration. Australian and New Zealand Journal of Public Health, 32(1), 90-92. [More Information]
  • Robotin, M., George, J., Supramaniam, R., Sitas, F., Penman, A. (2008). Preventing primary liver cancer: how well are we faring towards a national hepatitis B strategy? Medical Journal of Australia, 188(6), 363-365. [More Information]
  • Robotin, M. (2008). Successful lung transplantation for adolescents at a hospital for adults. Medical Journal of Australia, 188(7), 430-1. [More Information]
  • Robotin, M., Penman, A. (2006). Integrating complementary therapies into mainstream cancer care: which way forward? Medical Journal of Australia, 185(7), 377-379. [More Information]
  • Robotin, M., Law, M., Milliken, S., Goldstein, D., Garsia, R., Dolan, G., Kaldor, J., Grulich, A. (2004). Clinical characteristics and determinants of survival following AIDS- related non-Hodgkin’s lymphoma in a population-based case series in Sydney, Australia. HIV Medicine, 5, 377-384.
  • Robotin, M., Copland, J., Tallis, G., Coleman, D., Giele, C., Carter, L., Spencer, J., Kaldor, J., Dore, G. (2004). Surveillance for newly acquired hepatitis C in Australia. Journal of Gastroenterology and Hepatology, 19(3), 283-288.

Original Creative Work

  • Feletto, E., Gibberd, A., Kahn, C., Armstrong, K., Canfell, K., Chiew, M., Grogan, P., Nickson, C., O'Connell, D., Penman, A., Robotin, M., Smith, D., Yu, X., Sitas, F., et al (2013). The State of Cancer Control in Australia 1987–2007: Changes in cancer incidence and mortality, (pp. 1 - 166). Sydney, Australia: Cancer Council NSW.
  • Feletto, E., Gibberd, A., Kahn, C., Armstrong, K., Canfell, K., Chiew, M., Grogan, P., Nickson, C., O'Connell, D., Penman, A., et al (2013). The State of Cancer Control in Australia: 1987–2007: Changes in cancer incidenceand mortality, (pp. 1 - 166). NSW, Australia: Cancer Council NSW.
  • Robotin, M., Holliday, C. (2013). Cancer. Research priorities for complementary medicine in Australia - Chapter 5: Cancer, (pp. 35 - 42). Campbelltown, Australia: National Institute of Complementary Medicine.

2013

  • Feletto, E., Gibberd, A., Kahn, C., Armstrong, K., Canfell, K., Chiew, M., Grogan, P., Nickson, C., O'Connell, D., Penman, A., Robotin, M., Smith, D., Yu, X., Sitas, F., et al (2013). The State of Cancer Control in Australia 1987–2007: Changes in cancer incidence and mortality, (pp. 1 - 166). Sydney, Australia: Cancer Council NSW.
  • Feletto, E., Gibberd, A., Kahn, C., Armstrong, K., Canfell, K., Chiew, M., Grogan, P., Nickson, C., O'Connell, D., Penman, A., et al (2013). The State of Cancer Control in Australia: 1987–2007: Changes in cancer incidenceand mortality, (pp. 1 - 166). NSW, Australia: Cancer Council NSW.
  • Robotin, M., Holliday, C. (2013). Cancer. Research priorities for complementary medicine in Australia - Chapter 5: Cancer, (pp. 35 - 42). Campbelltown, Australia: National Institute of Complementary Medicine.
  • Sitas, F., Gibberd, A., Kahn, C., Weber, M., Chiew, M., Supramaniam, R., Velentzis, L., Nickson, C., Smith, D., O'Connell, D., Yu, X., Canfell, K., Robotin, M., et al (2013). Cancer incidence and mortality in people aged less than 75 years: Changes in Australia over the period 1987-2007. Cancer Epidemiology, 37(6), 780-787. [More Information]
  • Robotin, M., Patton, Y., George, J. (2013). Getting it right: The impact of a continuing medical education program on hepatitis B knowledge of Australian primary care providers. International Journal of General Medicine, 6(115), 122. [More Information]

2012

  • Robotin, M., Patton, Y., Kansil, M., Penman, A., George, J. (2012). Cost of treating chronic hepatitis B: Comparison of current treatment guidelines. World Journal of Gastroenterology, 18(42), 6106-6113. [More Information]
  • Robotin, M., Holliday, C., Bensoussan, A. (2012). Defining research priorities in complementary medicine in oncology. Complementary Therapies in Medicine, 20(5), 345-352. [More Information]
  • Robotin, M. (2012). From Traditional Medicines to Drug Discovery. In Olver, I and Robotin, M (Eds.), Perspectives on Complementary and Alternative Medicines, (pp. 157-185). London: Imperial College Press.
  • Oliver, I., Robotin, M. (2012). Perspectives on Complementary and Alternative Medicines. London: Imperial College Press.

2011

  • Robotin, M. (2011). Botanical products in the 21st century: from whence to whither. Cancer Forum, 35(1), 6-9.
  • Robotin, M. (2011). Hepatitis B prevention and control: Lessons from the East and the West. World Journal of Hepatology, 3(2), 31-37. [More Information]
  • Robotin, M. (2011). Randomised Controlled Trials in the Primary Treatment of Hepatocellular Carcinoma. In Liang Qiao, Yumin Li, Xiang Yan & Jacob George (Eds.), Molecular Aspects of Hepatocellular Carcinoma, (pp. 174-195). Sharjah: Bentham Science Publishers Ltd.

2010

  • Robotin, M., Jones, S., Biankin, A., Waters, L., Iverson, D., Gooden, H., Barraclough, B., Penman, A. (2010). Defining research priorities for pancreatic cancer in Australia: results of a consensus development process. Cancer Causes and Control: an international journal of studies of cancer in human populations, 21(5), 729-736. [More Information]
  • Robotin, M. (2010). Enquiring about cancer patients' use of complementary and alternative medicines: Is our job done? Asia-Pacific Journal of Clinical Oncology, 6(4), 245-247. [More Information]
  • Holliday, C., Robotin, M. (2010). The Delphi process: a solution for reviewing novel grant applications. International Journal of General Medicine, 3, 225-230. [More Information]
  • Robotin, M., Kansil, M., George, J., Howard, K., Tipper, S., Levy, M., Phung, N., Penman, A. (2010). Using a population-based approach to prevent hepatocellular cancer in New South Wales, Australia: effects on health services utilisation. BMC Health Services Research, 10, 215-224. [More Information]
  • Sundquist, K., Robotin, M. (2010). What matters to patients and to carers. In Monica Robotin, Ian Olver and Afaf Girgis (Eds.), When Cancer Crosses Disciplines: A Physician's Handbook, (pp. 317-341). London: Imperial College Press.
  • Robotin, M., Olver, I., Girgis, A. (2010). When Cancer Crosses Disciplines: A Physician's Handbook. London: Imperial College Press.

2009

  • Robotin, M., Kansil, M., Howard, K., George, J., Tipper, S., Dore, G., Levy, M., Penman, A. (2009). Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screening. Journal of Hepatology, 50(5), 990-998. [More Information]
  • Saunders, C., Gooden, H., Robotin, M., Mumford, J. (2009). As the bell tolls: a foundation study on pancreatic cancer consumer's research priorities. BMC Research Notes, 2(179), 1-9. [More Information]
  • Alam, N., Robotin, M., Baker, D. (2009). Epidemiology of primary liver cancer. Cancer Forum, 33(2), 88-92.
  • George, J., Robotin, M. (2009). Overview: Hepatocellular carcinoma - the future starts now. Cancer Forum, 33(2), 83-87.

2008

  • Matthews, G., Robotin, M. (2008). B positive-all you wanted to know about hepatitis B: a guide for primary care providers. Australia: ASHM - Australasian Society for HIV Medicine.
  • Saunders, C., Robotin, M., Crossing, S. (2008). By invitation only - the case for breast cancer screening reminders for women over 69 years. Australia and New Zealand Health Policy, 5(23), 23-1-23-6. [More Information]
  • Supramaniam, R., O'Connell, D., Robotin, M., Tracey, E., Sitas, F. (2008). Future cancer trends to be influenced by past and future migration. Australian and New Zealand Journal of Public Health, 32(1), 90-92. [More Information]
  • Robotin, M. (2008). Hepatitis b virus-related hepatocellular carcinoma. In Gail Matthews and Monica Robotin (Eds.), B positive-all you wanted to know about hepatitis B: a guide for primary care providers, (pp. 69-74). Australia: ASHM - Australasian Society for HIV Medicine.
  • Robotin, M., George, J., Supramaniam, R., Sitas, F., Penman, A. (2008). Preventing primary liver cancer: how well are we faring towards a national hepatitis B strategy? Medical Journal of Australia, 188(6), 363-365. [More Information]
  • Robotin, M. (2008). Successful lung transplantation for adolescents at a hospital for adults. Medical Journal of Australia, 188(7), 430-1. [More Information]

2006

  • Robotin, M., Penman, A. (2006). Integrating complementary therapies into mainstream cancer care: which way forward? Medical Journal of Australia, 185(7), 377-379. [More Information]

2004

  • Robotin, M., Law, M., Milliken, S., Goldstein, D., Garsia, R., Dolan, G., Kaldor, J., Grulich, A. (2004). Clinical characteristics and determinants of survival following AIDS- related non-Hodgkin’s lymphoma in a population-based case series in Sydney, Australia. HIV Medicine, 5, 377-384.
  • Robotin, M., Copland, J., Tallis, G., Coleman, D., Giele, C., Carter, L., Spencer, J., Kaldor, J., Dore, G. (2004). Surveillance for newly acquired hepatitis C in Australia. Journal of Gastroenterology and Hepatology, 19(3), 283-288.

To update your profile click here. For support on your academic profile contact .